D59.39 - Other hemolytic-uremic syndrome
- Applicable to Other hemolytic-uremic syndrome
- The 2025 edition of ICD10-CM D59.39 became effective on October 1, 2024.
- This is the American ICD10-CM version of D59.39 - other international versions of ICD10 D59.39 may differ.
- D59.39 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Code Additional Code
- code, if applicable, for adverse effect to identify drug (T36-T50 with fifth or sixth character 5)
Inclusion Term
- Atypical (nongenetic) hemolytic uremic syndrome
- Secondary hemolytic-uremic syndrome
codefirst
- , if applicable, any associated:
- COVID-19 (U07.1)
- complications of kidney transplant (T86.1-)
- complications of heart transplant (T86.2-)
- complications of liver transplant (T86.4-)
codeAlso
- , if applicable, any associated condition, such as:
- hypertensive emergency (I16.1)
- malignant neoplasm (C00-C96)
- systemic lupus erythematosus (M32.-)
The following codes above D59.39 contain annotation back-references that may be applicable to D59.39:
Section: D55-D59 Hemolytic anemias
Category: D59 Acquired hemolytic anemia
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com